Emergence of hepatitis B virus gene mutation related to entecavir-resistance in chronic hepatitis B patients participated in the phase 2 clinical studies of entecavir in Japan

被引：0
|
作者：
Kobashi, Haruhiko
Fujioka, Shin-ichi
Kumada, Hiromitsu
Yokosuka, Osamu
Hayashi, Norio
Suzuki, Kazuyuki
Okanoue, Takeshi
Sata, Michio
Tsubouchi, Hirohito
Sato, Chifumi
Kiyosawa, Kendo
Takaki, Akinobu
Iwasaki, Yoshiaki
Sakaguchi, Kosaku
Shiratori, Yasushi
Ishikawa, Hiroki
Seriu, Taku
Omata, Masao
机构：
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan
[2] Okayama Saiseikai Gen Hosp, Dept Med, Okayama, Japan
[3] Toranomon Gen Hosp, Ctr Liver Dis, Kanagawa, Japan
[4] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan
[5] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Osaka, Japan
[6] Iwate Med Univ, Dept Internal Med 1, Iwate, Japan
[7] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan
[8] Kurume Univ, Sch Med, Dept Gastroenterol, Fukuoka, Japan
[9] Kagoshima Univ, Kagoshima 890, Japan
[10] Tokyo Med & Dent Univ, Grad Sch Allied Hlth Sci, Dept Analyt Hlth Sci, Tokyo, Japan
[11] Shinshu Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Matsumoto, Nagano 390, Japan
[12] Kurume Univ, Int Inst Liver Res, Kurume, Fukuoka 830, Japan
[13] Univ Tokyo, Fac Med, Dept Gastroenterol, Tokyo, Japan
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
963
引用
收藏
页码：666A / 666A
页数：1
相关论文
共 50 条
  • [1] TENOFOVIR VERSUS TENOFOVIR PLUS ENTECAVIR FOR CHRONIC HEPATITIS B WITH LAMIVUDINE-RESISTANCE AND ENTECAVIR-RESISTANCE
    Lee, S.
    Ahn, S. H.
    Jung, K. S.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Baatarkhuu, O.
    Ku, H. J.
    Han, K-H
    Park, J. Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S595 - S595
  • [2] Hepatitis B virus resistance to entecavir
    Hidalgo-Tenorio, Carmen
    Rivero, Mar
    Alvarez, Marta
    Garcia, Federico
    MEDICINA CLINICA, 2012, 139 (05): : 228 - 229
  • [3] ENTECAVIR RESISTANCE IN ENTECAVIR NAIVE LAMIVUDINE TREATED CHRONIC HEPATITIS B PATIENTS
    Sayan, Murat
    Hulagu, Sadettin
    Akhan, Sila Cetin
    Senturk, Omer
    Meric, Meliha
    Cekmen, Mustafa
    MIKROBIYOLOJI BULTENI, 2009, 43 (03): : 425 - 432
  • [4] Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
    Nam, Joon Yeul
    Lee, Jeong-Hoon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (04) : 311 - 313
  • [5] Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B
    Takayama, Hideo
    Komura, Takuya
    Kagaya, Takashi
    Sugimoto, Saiho
    Orita, Noriaki
    Asahina, Yoshiro
    Nishikawa, Masashi
    Ohta, Hajime
    Kaneko, Shuichi
    Unoura, Masashi
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
  • [6] Clinical utility of entecavir for chronic hepatitis B in Chinese patients
    Wang, Jiyao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 13 - 24
  • [7] Entecavir for the treatment of chronic hepatitis B virus infection
    Matthews, SJ
    CLINICAL THERAPEUTICS, 2006, 28 (02) : 184 - 203
  • [8] Resistance Mutations of Hepatitis B Virus in Entecavir-Refractory Patients
    Yamada, Norie
    Sugiyama, Ryuichi
    Nitta, Sayuri
    Murayama, Asako
    Kobayashi, Minoru
    Okuse, Chiaki
    Suzuki, Michihiro
    Yasuda, Kiyomi
    Yotsuyanagi, Hiroshi
    Moriya, Kyoji
    Koike, Kazuhiko
    Wakita, Takaji
    Kato, Takanobu
    HEPATOLOGY COMMUNICATIONS, 2017, 1 (02) : 110 - 121
  • [9] Entecavir (Baraclude) in patients with chronic hepatitis B virus (HPV) infection
    Sacchi, Viola
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2008, 9 (03) : 157 - 161
  • [10] Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir
    Bang, Ki Bae
    Kim, Hong Joo
    Cho, Yong Kyun
    Kim, Byung Ik
    HEPATOLOGY, 2013, 58 : 683A - 683A
12345